Resources from the same session
Molecular characterisation of urothelial cancer
Presenter: Holger Moch
Session: Individualised therapy in advanced urothelial cancer: Prime time?
Resources:
Slides
Webcast
Chemotherapy, immunotherapy or combinations: What is the best option in the face of new evidence?
Presenter: Alison Birtle
Session: Individualised therapy in advanced urothelial cancer: Prime time?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Alison Birtle
Session: Individualised therapy in advanced urothelial cancer: Prime time?
Resources:
Webcast